Cargando…
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
UHRF1 (ubiquitin-like with PHD and ring finger domains 1) is highly expressed in various human cancers including retinoblastoma, and associated with tumor-promoting effects such as inhibition of apoptosis and high proliferation. However, the molecular mechanisms underlying tumor-promoting functions...
Autores principales: | He, Heng, Lee, Chunsik, Kim, Jong Kyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833858/ https://www.ncbi.nlm.nih.gov/pubmed/29415984 http://dx.doi.org/10.1038/s41419-017-0203-4 |
Ejemplares similares
-
UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
por: Kim, Jong Kyong, et al.
Publicado: (2019) -
Functional dissection of the role of UHRF1 in the regulation of retinoblastoma methylome
por: Kan, Guangyan, et al.
Publicado: (2017) -
Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities
por: Lee, Chunsik, et al.
Publicado: (2022) -
Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications
por: Lee, Chunsik, et al.
Publicado: (2020) -
GSDME Increases Chemotherapeutic Drug Sensitivity by Inducing Pyroptosis in Retinoblastoma Cells
por: Li, Fang, et al.
Publicado: (2022)